Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT02638168. We help you review the study, but cannot decide medical eligibility.
TerminatedNCT02638168
Immediate Release Methylphenidate for ADHD
This study was terminated in the United States. It is testing immediate Release Methylphenidate for ADHD.
ADHD, Attention Deficit Disorder With Hyperactivity, ...DrugFrom 6 Years to 12 Years
Understand this study
Who could participate?
Listed age limits: 6 years to 12 years.
- Listed locations
- Hershey, United StatesSee all locations and recruitment
Compensation and expense reimbursement have not been verified for this summary.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJanuary 2016
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 3
- Sponsor
- Milton S. Hershey Medical Center
- Sponsor type
- Individual investigator
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 6 Years to 12 Years
- Official registry ID
- NCT02638168
- Official title
- Effects of Evening Dose of Immediate Release Methylphenidate on Sleep in Children With Attention Deficit Hyperactivity Disorder: A Randomized Placebo-controlled Pilot Study
Recruitment & locations
TerminatedHershey
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is Milton S. Hershey Medical Center.
Does this study involve medication?
Yes. The study involves medication, including Immediate Release Methylphenidate and Placebo.
Who can participate?
Listed age limits: 6 years to 12 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit meExplore related studies
Other studies that may be relevant based on condition, country, or study type.
TerminatedNCT01721330
A Comparison of Naltrexone and Placebo in Adults With Attention Deficit Hyperactivity Disorder
This study was terminated in the United States. It focuses on ADHD.
TerminatedNCT06673368
Parallel, Adaptive-Design, study Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder
This study was terminated in the United States. It focuses on ADHD.
TerminatedNCT00554385
A Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD)
This study has public registry information. It focuses on ADHD and currently lists study information in the United States.